How this new biotech billionaire outmanoeuvred Merck in China
Michelle Xia gained experience at U.S. pharmaceutical firms before launching her own biotech company back home in China. In a trial last year, the firm’s cancer drug outperformed the world’s best seller–and its surging stock just made her a billionaire. This story appears in Issue 19 of Forbes Australia, out now. Tap here to secure your […]